Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

The Effectiveness of an Exercise Program on Scapulohumeral Rhythm, Range of Motion, and Stability in Young Female Handball Players

NCT06875596 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2025-03-08
Last updated
2026-05-07

Condition(s) studied

Scapular DyskinesisHandball PlayersFemale Athlete

Investigational drug(s) / intervention(s)

Modified Watson-based scapular exercise programActive Comparator: Standard upper-limb exercise program

Modified Watson-based scapular exercise program: An 8-week dominant-limb exercise program based on the Watson rehabilitation approach, incorporating scapular positioning correction, scapular-specific cueing, and progressive exercises performed with two elastic resistance bands.

Active Comparator: Standard upper-limb exercise program: An 8-week dominant-limb standardized upper-limb exercise program performed with one elastic resistance band and without scapular positioning correction or scapular-specific cueing.

Study summary

This record describes a planned randomized parallel-group trial of a modified Watson-based shoulder exercise program in female handball players. An internal pilot phase was conducted first to evaluate feasibility and obtain preliminary estimates to inform the definitive trial.

Eligibility

Sex
FEMALE
Min age
16 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy individuals with no reported health problems * No history of shoulder or elbow surgery within the past 2 years * Received information about the study * Written consent from the participant to participate in the study, including video recording and photography Exclusion criteria: * Injury or trauma to the upper extremity within the past 3 months * Illness that prevents participation in the study or tests * Heavy physical activity of the shoulder girdle within 2 hours prior to the study * Orthopedic surgery or physiotherapy treatment of the shoulder girdle

Primary outcome measure(s)

  • Scapulohumeral rhythm — through study completion, an average of 2 years
    Scapular upward rotation is assessed with the Digital Inclinometer (BASELINE 12-1057) in a seated position to minimize compensatory movements of the trunk and lower extremities. The first measurement is taken at baseline (0° of shoulder flexion), followed by additional measurements at 30°, 60°, 90°, and 120° of shoulder flexion. Each position is held for 10-15 seconds to ensure stable measurement conditions. Measurements are repeated three times and the average is used for analysis. The assessment will be performed on both the dominant and non-dominant upper limb to evaluate movement symmetry. Data will be recorded manually by a research assistant to reduce the risk of reading errors and to ensure measurement accuracy. Statistical analysis will be performed to determine the scapulohumeral rhythm across different ranges of motion and to identify potential movement asymmetries.
  • ISOMETRIC STRENGTH TEST - Internal and External Rotation — through study completion, an average of 2 years
    Isometric strength assessment of the shoulder girdle muscles will be conducted using the Lafayette Hand-Held Dynamometer (HHD). For the rotator muscles, measurements will be performed in the prone position with the shoulder abducted to 90° and the elbow flexed to 90°, with the forearm hanging freely over the edge of the examination table. This setup will be used for both internal and external rotation strength assessments. Results are expressed in Newtons (N) or normalized to body weight as Newtons per kilogram (N/kg).
  • Y-Balance Upper Quarter Test (YBT-UQ) — through study completion, an average of 2 years
    The Y-Balance Upper Quarter Test (YBT-UQ) is used to assess upper extremity stability and reach performance. The test requires the participant to maintain a single-arm support position while the opposite arm performs reaching movements in three directions: anterior (forward), inferolateral (diagonally opposite the supporting hand), and superolateral (diagonally toward the supporting hand). Each reach is measured in centimeters, and the final score for each direction is calculated as the average of three trials. The test will be performed on both upper limbs and arm length will be included in the analysis to ensure standardized results. Results will be reported in centimeters, "cm", and Upper Limb Length % (standardized by upper limb length).

Trial sites (1)

FacilityCityRegionStatus
Department of Immunobiology and Environment Microbiology, Medical University of Gdańsk Gdansk Pomeranian Voivodeship
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06875596 on ClinicalTrials.gov ↗ ← All trials in Poland